statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Scholar Rock (NASDAQ: SRRK; the Company), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious...

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

This is a signal that SRRK's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Scholar Rock Holding (SRRK, $16.79) Stochastic Oscillator left the overbought zone on April 01, 2024

Denali Advisors LLC decreased its holdings in shares of Scholar Rock Holding Co. (NASDAQ:SRRK - Free Report) by 40.9% in the 4th quarter, according to the company in its most recent disclosure with...

Scholar Rock Holding Co. (NASDAQ:SRRK) Position Trimmed by Denali Advisors LLC

This price move could indicate a change in the trend, and may be a buy signal for investors...

Scholar Rock Holding (SRRK, $17.76) price moved above its 50-day Moving Average on March 28, 2024

This indicator may be signaling SRRK's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Scholar Rock Holding (SRRK, $17.76) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

This is a Bullish indicator signaling SRRK's price could rise from here. Traders may explore going long the stock or buying call options...

Scholar Rock Holding (SRRK, $17.76) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 28, 2024

Raymond James has initiated coverage on Scholar Rock Holding (NASDAQ:SRRK), supported by the potential value with a couple of key programs utilizing selective myostatin inhibition to
read more...

Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst

For the last three days, A.I.dvisor has detected that SRRK's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Scholar Rock Holding (SRRK, $15.48) Aroon Indicator entered a Downtrend on March 27, 2024.

This is a Bearish indicator signaling SRRK's price could decline from here. Traders may explore shorting the stock or put options...

Scholar Rock Holding (SRRK, $15) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 26, 2024

Scholar Rock Holding (SRRK, $15) Stochastic Oscillator left the overbought zone on March 26, 2024

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Volume	498,572.00
52-Wk High	$21.17
52-Wk Low	$5.56

SRRK Scholar Rock Holding Corp

About

Feed

News

Sentiment

Earnings

Fundamentals